Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 543 of 1,261
  1. US 10080749

    Multi-drug therapies for tuberculosis treatment

    The Regents of the University of California · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  2. US 10080739

    Aryl imidazoles and their use as anti-cancer agents

    APTOSE BIOSCIENCES INC. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  3. US 10080745

    Piericidin bacterial inhibitors

    The Regents of the University of California Santa Cruz · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  4. US 10080799

    Methods and compositions related to glycoprotein-immunoglobulin fusions

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  5. US 10081661

    Methods and compositions for genome engineering

    Sangamo Therapeutics, Inc. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  6. US 10082496

    Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis

    The Board of Regents of the University of Texas System · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  7. US 10081811

    Organic compositions to treat Beta-ENaC-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  8. US 10081632

    Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitors

    PHOENIX MOLECULAR DESIGNS · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  9. US 10081668

    Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  10. US 10081659

    Adeno-associated vectors for enhanced transduction and reduced immunogenicity

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  11. US 10081658

    Truncated HIV envelope proteins (ENV), methods and compositions related thereto

    The United States of America as represented by the Secretary of the Army · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  12. US 10081624

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  13. US 10081602

    Opioid agonists and uses thereof

    Nektar Therapeutics · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  14. US 10080803

    Emulsified krill phospholipid compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  15. US 10080790

    Staphylococcus aureus materials and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  16. US 10080775

    Peptide having skin whitening activity, and use thereof

    CAREGEN CO., LTD. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  17. US 10080774

    Oncolytic adenovirus armed with therapeutic genes

    The Board of Regents of the University of Texas System · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  18. US 10080770

    Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

    RegenLab USA LLC · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  19. US 10080743

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  20. US 10080742

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  21. US 10080741

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  22. US 10080740

    Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  23. US 10080730

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  24. US 10080720

    Pharmaceutical composition containing docetaxel

    GAINIA (SHANGHAI) PATENT TECHNOLOGY LTD. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.